Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 34, 2020 - Issue 20
118
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Three new triterpenoids with their bioactives from the roots of Rosa cymosa

, , &
Pages 2931-2937 | Received 23 Dec 2018, Accepted 20 Mar 2019, Published online: 18 Oct 2019
 

Abstract

Three new triterpenoids, 2α, 3α, 20β, 23-tetrahydroxyurs-13 (18)-en-28-oic-acid (1) (Figure 1), 2β, 3α, 20β, 23-tetrahydroxyurs-13(18)-en-28-oic-acid (2), and 2α, 3α-dihydroxyurs-12(13), 18(19)-dien-28-oic-acid (3) were isolated from the roots of R. cymosa. Their structures were elucidated by extensive spectroscopic methods, including NMR, MS, and IR spectroscopic analyses data. All the isolates were evaluated for their α-glucosidase inhibitory and anti-inflammatory activities in vitro. The results showed that compound 2 displayed moderate anti-inflammatory activity with IC50 value of 9.4 μM.

Graphical Abstract

Acknowledgements

This work was financially supported by the technological platform for comprehensive research and development of new drugs in the Twelfth Five-Year “Significant New Drugs Created” Science and Technology Major Projects (No. 2012ZX09301-002-001-026), the National Science and Technology Support Program (No. 2012BA127B06).

Disclosure statement

No potential conflict of interest was reported by the authors.

Figure 1. Structures of compounds 1–3.

Figure 1. Structures of compounds 1–3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.